• MATFLIX

SERIES 2: Episode 8 - Sickle cell and blood disorders in pregnancy

In this eighth episode of Midwifery Hour series two, Dr Jenny Hall, Editor, MATFLIX was joined by Rachel Kesse-Adu, Consultant Haematologist, Guy’s ant St Thomas’ NHS Foundation Trust and Joyce Adu-Amankwah, Specialist Haemoglobinopathies Midwife, St. George’s Hospital NHS Trust.


This episode explores antenatal and newborn testing, care & family support for birthing woman with sickle cell and other haemaglobinopathies during pregnancy, in particular ethnic groups who are most at risk.

Joyce Adu-Amankwah, Specialist Haemoglobinopathies Midwife, and Consultant Haematologist Rachel Kesse-Adu speak about the challenges presented during COVID-19 when providing contemporary care, including an overview of the biological and pathophysiological background of Haemoglobinopathies.

The midwifery aspects of supporting women and families, including client centred care to pregnant and childbearing women with Haemoglobinopathies are highlighted in each presentation.


This episode of the Maternity & Midwifery Hour – proudly supported by MATFLIX – focused on 'Sickle cell and blood disorders in pregnancy'


Host Dr Jenny Hall (Editor, MATFLIX) was joined by Rachel Kesse-Adu (Consultant Haematologist, Guy’s ant St Thomas’ NHS Foundation Trust) and Joyce Adu-Amankwah (Specialist Haemoglobinopathies Midwife, St. George’s Hospital NHS Trust).



Watch the Maternity & Midwifery Hour highlights now:


Joyce Adu-Amankwah



Rachel Kesse-Adu


Dr Jenny Hall


You can listen to the episode on your podcast app of choice: Spotify, Apple Podcasts or Anchor.


DATE FOR YOUR DIARY: The next episode will be hosted by Jenny Hall, will go out LIVE via the Maternity and Midwifery Facebook here.


Register your place here for Episode 9: Dismantling racism & inequalities in midwifery education


See all references and resources from Series 1 and 2 here.

19 views

United Kingdom and Republic of Ireland  |  Registration Number 8390093.

© 2019 MATFLIX. All rights reserved

  • Facebook
  • Twitter
  • YouTube
  • Instagram